AVNS
AVNS
NYSE · Health Care

Avanos Medical Inc

$14.09
+0.08 (+0.57%)
Financial Highlights (FY 2026)
Revenue
681.08M
Net Income
-388,267,252
Gross Margin
55.4%
Profit Margin
-57.0%
Rev Growth
-2.6%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 55.4% 55.4% 62.5% 62.5%
Operating Margin -57.6% -51.8% 19.2% 18.9%
Profit Margin -57.0% -54.2% 15.7% 17.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 681.08M 699.33M 134.83M 155.65M
Gross Profit 377.59M 387.71M 84.30M 97.32M
Operating Income -392,301,525 -362,533,496 25.89M 29.38M
Net Income -388,267,252 -358,805,346 21.13M 26.73M
Gross Margin 55.4% 55.4% 62.5% 62.5%
Operating Margin -57.6% -51.8% 19.2% 18.9%
Profit Margin -57.0% -54.2% 15.7% 17.2%
Rev Growth -2.6% -2.6% +2.6% +23.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 49.37M 49.37M 313.58M 310.39M
Total Equity 303.64M 303.64M 338.13M 361.58M
D/E Ratio 0.16 0.16 0.93 0.86
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -347,271,871 -338,749,643 34.86M 46.09M
Free Cash Flow 16.58M 14.70M